Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1957 1
1958 1
1959 2
1968 2
1990 1
1992 2
1994 2
1995 3
1996 1
1997 4
1998 6
1999 3
2000 6
2001 2
2002 2
2003 8
2004 3
2005 2
2006 1
2007 4
2008 7
2009 7
2010 5
2011 8
2012 8
2013 24
2014 51
2015 76
2016 78
2017 92
2018 107
2019 117
2020 121
2021 147
2022 106
2023 119
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

1,017 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for sur yon
Your search for Suro Yoon retrieved no results
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.
Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, Louis G, Moschietto S, Titeca-Beauport D, Combe B, Pons B, de Prost N, Besset S, Combes A, Robine A, Beuzelin M, Badie J, Chevrel G, Bohé J, Coupez E, Chudeau N, Barbar S, Vinsonneau C, Forel JM, Thevenin D, Boulet E, Lakhal K, Aissaoui N, Grange S, Leone M, Lacave G, Nseir S, Poirson F, Mayaux J, Asehnoune K, Geri G, Klouche K, Thiery G, Argaud L, Rozec B, Cadoz C, Andreu P, Reignier J, Ricard JD, Quenot JP, Dreyfuss D. Gaudry S, et al. Lancet. 2021 Apr 3;397(10281):1293-1300. doi: 10.1016/S0140-6736(21)00350-0. Lancet. 2021. PMID: 33812488 Clinical Trial.
Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies.
Gaudry S, Grolleau F, Barbar S, Martin-Lefevre L, Pons B, Boulet É, Boyer A, Chevrel G, Montini F, Bohe J, Badie J, Rigaud JP, Vinsonneau C, Porcher R, Quenot JP, Dreyfuss D. Gaudry S, et al. Crit Care. 2022 Apr 4;26(1):93. doi: 10.1186/s13054-022-03955-9. Crit Care. 2022. PMID: 35379300 Free PMC article. Clinical Trial.
In reply.
Boisdron-Celle M, Capitain O, Faroux R, Borg C, Philippe Metges J, Galais MP, Kaassis M, Bennouna J, Bouhier-Leporrier K, Francois E, Baumgaertner I, Guerin-Meyer V, Cojocarasu O, Roemer-Becuwe C, Stampfli C, Rosenfeld L, Lecompte T, Berger V, Morel A, Gamelin E. Boisdron-Celle M, et al. Semin Oncol. 2017 Apr;44(2):161. doi: 10.1053/j.seminoncol.2017.08.002. Epub 2017 Aug 4. Semin Oncol. 2017. PMID: 28923216 No abstract available.
[Thinking about the caregiver].
Taupin-Meignen N, Longuechaud C, Haute JC. Taupin-Meignen N, et al. Rev Infirm. 2022 Apr;71(280):45-48. doi: 10.1016/j.revinf.2022.02.017. Epub 2022 Mar 8. Rev Infirm. 2022. PMID: 35550101 Review. French.
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram.
Grégoire M, Dailly E, Le Turnier P, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme YM, Hoff J, Lemaitre F, Verdier MC, Deslandes G, Bellouard R, Sébille V, Chiffoleau A, Boutoille D, Navas D, Asseray N. Grégoire M, et al. Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00634-19. doi: 10.1128/AAC.00634-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31235630 Free PMC article. Clinical Trial.
Management of septic bursitis.
Lormeau C, Cormier G, Sigaux J, Arvieux C, Semerano L. Lormeau C, et al. Joint Bone Spine. 2019 Oct;86(5):583-588. doi: 10.1016/j.jbspin.2018.10.006. Epub 2018 Oct 26. Joint Bone Spine. 2019. PMID: 31615686 Review.
1,017 results